Gloria Crepaldi

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Temporo-mandibular joint alterations in juvenile idiopathic arthritis and young-onset inflammatory arthropathies: a magnetic resonance imaging study with ultrasound comparison.

Temporo-mandibular joint alterations in juvenile idiopathic arthritis and young-onset inflammatory arthropathies: a magnetic resonance imaging study with ultrasound comparison.

Journal: Pediatric rheumatology online journal

Published: November 17, 2025

Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS study.

Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS study.

Journal: Arthritis research & therapy

Published: June 03, 2025

Retention rate and predictors of discontinuation for secukinumab treatment: real-life data in a cohort of patients with spondyloarthritis.

Retention rate and predictors of discontinuation for secukinumab treatment: real-life data in a cohort of patients with spondyloarthritis.

Journal: Clinical and experimental rheumatology

Published: November 14, 2024

Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study.

Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study.

Journal: Rheumatology and therapy

Published: July 03, 2024

Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study.

Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study.

Journal: Journal of personalized medicine

Published: June 03, 2024

The Retention Rate and Safety of JAK Inhibitors in Rheumatoid Arthritis: Real Word Data from a Monocentric Cohort.

The Retention Rate and Safety of JAK Inhibitors in Rheumatoid Arthritis: Real Word Data from a Monocentric Cohort.

Journal: Journal of clinical medicine

Published: April 23, 2024

Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study.

Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study.

Journal: RMD open

Published: January 08, 2024

New onset sarcoidosis following biologic treatment in patients with seronegative inflammatory arthritis: A case series and systematic literature review.

New onset sarcoidosis following biologic treatment in patients with seronegative inflammatory arthritis: A case series and systematic literature review.

Journal: Autoimmunity reviews

Published: November 06, 2023

Psoriatic Dactylitis: Current Perspectives and New Insights in Ultrasonography and Magnetic Resonance Imaging.

Psoriatic Dactylitis: Current Perspectives and New Insights in Ultrasonography and Magnetic Resonance Imaging.

Journal: Journal of clinical medicine

Published: May 19, 2021

Osteopoikilosis hiding active sacroiliitis in Psoriatic Arthritis.

Osteopoikilosis hiding active sacroiliitis in Psoriatic Arthritis.

Journal: Rheumatology (Oxford, England)

Published: July 20, 2019

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

Journal: Rheumatology (Oxford, England)

Published: August 11, 2017

Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis.

Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis.

Journal: PloS one

Published: September 23, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026